SCHEMBL24977263

SCHEMBL24977263

CC(C)(C)c1ccc(Oc2ccc(-c3cccnc3)cc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.81
CYP19A1 P11511 4/20 0.53
CYP3A4 P08684 3/20 0.53
CYP2C19 P33261 2/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
ALDH1A1 P00352 4/20 0.51
THRB P10828 1/20 0.51
CYP11B2 P19099 5/20 0.49
CYP17A1 P05093 3/20 0.49
CYP11B1 P15538 3/20 0.49
CYP2A6 P11509 2/20 0.48
CYP1A2 P05177 2/20 0.48
NPC1 O15118 2/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
MKNK1 Q9BUB5 2/20 0.45
MKNK2 Q9HBH9 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1623940 0.90 KIF11 (1.00) KIF11CYP19A1CYP3A4CYP2C19CYP2D6
SCHEMBL23666164 0.90 KIF11 (1.00) KIF11CYP19A1CYP3A4CYP2C19CYP2D6
SCHEMBL10150461 0.85 LMNA (0.56) KIF11CYP19A1ALDH1A1THRBCYP11B2
SCHEMBL2250286 0.82 KIF11 (0.83) KIF11CYP19A1CYP3A4ALDH1A1THRB
SCHEMBL21345924 0.81 CYP3A4 (0.57) KIF11CYP19A1CYP3A4CYP2C19CYP2D6
SCHEMBL21346444 0.81 ALDH1A1 (0.52) KIF11ALDH1A1THRBNPC1HPGD
SCHEMBL22904695 0.81 KIF11 (0.77) KIF11CYP3A4CYP2D6ALDH1A1NPC1
SCHEMBL7013344 0.81 CYP11B2 (0.60) KIF11CYP19A1CYP3A4CYP2C19CYP2D6
SCHEMBL23394825 0.80 RAB9A (0.68) KIF11ALDH1A1NPC1HPGDRAB9A
SCHEMBL18934226 0.80 RAB9A (0.68) KIF11ALDH1A1NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572337-B2 Antibacterial agents: arylalkylcarboxamido phloroglucinols RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572337-B2 Antibacterial agents: arylalkylcarboxamido phloroglucinols RNGTT, FBL, POLR1C KIF11 773/4885CYP19A1 3021/4885CYP3A4 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.